Stay updated on CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision (v3.3.2) was added, replacing the previous v3.3.1, which appears to be a minor update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed from the Study Record History.SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding status notice has been removed from the page, where it previously warned about funding-related delays and provided links to cc.nih.gov and opm.gov.SummaryDifference0.7%

- Check43 days agoChange DetectedA new entry appears in the Study Record Versions list indicating an updated record version; the rest of the page content remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference12%

- Check79 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.3%

Stay in the know with updates to CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page.